DESCRIPTION: Veterinary Medicine Raw Material Ciprofloxacin Hydrochloride is one of the outstanding representatives
of quinolone antibiotics. It was successfully developed by Bayer Pharmaceuticals in Germany in 1983. The first generation
of quinolone antibiotics is represented by nalidixic acid, the second generation is represented by pipemidic acid, and the
third generation is represented by nalidixic acid. The third generation is represented by norfloxacin. Ciprofloxacin has a
broad antibacterial spectrum and strong antibacterial activity, and is effective against both Gram-positive and Gram-negative
bacteria, as well as Pseudomonas aeruginosa, with few adverse reactions. It is a drug variety with large sales in the international
market, and domestic production is developing rapidly in China.
CAS NO.: 86483-48-9
CHARACTER: Ciprofloxacin Hydrochloride is white or slightly yellow crystalline powder; almost odorless, bitter taste.
This product is soluble in water, slightly soluble in methanol, very slightly soluble in ethanol, almost insoluble in
chloroform, and easily soluble in sodium hydroxide test solution.
USAGE: Ciprofloxacin hydrochloride is a quinolone antibiotic, broad-spectrum antibacterial drug, suitable for heavy mixed infection, mainly
used for chronic respiratory tract, Escherichia coli drugs, infectious rhinitis, fowl cholera, fowl typhoid, etc. It has a broad antibacterial spectrum
and strong antibacterial activity, and is effective against both Gram-positive and Gram-negative bacteria, as well as Pseudomonas aeruginosa,
with few adverse reactions.
